Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEG108844: Pazopanib versus Sunitinib in Locally Advanced and/or Metastatic Renal Cell Carcinoma
2008-002102-19Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in renal cell carcinoma (RCC) and metastatic renal cell carcinoma (mRCC) comparing Pazopanib with Sunitinib (2 arms). Started Jul 2008; status: completed.
02
Drugs
pazopanibsunitinib
03
Conditions
renal cell carcinoma (RCC)metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2008-002102-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002102-19.